A population-based study of secondary prostate cancer risk after radiotherapy in male patients with rectal cancer: A retrospective cohort study

Jen Pin Chuang, Yen Chien Lee, Jenq Chang Lee, Chin Li Lu, Chung Yi Li

Research output: Contribution to journalArticle

Abstract

Background and objective: Risk of secondary prostate cancer after radiation therapy among patients with rectal cancer remains undetermined. Given an increased incidence of rectal cancer in younger people and improved survival for rectal cancer patients who received radiation therapy, the potential risk of secondary prostate cancer needs to be further investigated. Materials and Methods: Male patients (n = 11,367) newly diagnosed rectal cancer and who underwent abdominoperineal resection (APR) or low anterior resection (LAR) from 1 January, 1998 to 31 December, 2010 were identified from Taiwan National Health Insurance Research Database. The incidence and relative risk of secondary prostate cancer in study patients with (n = 1586) and without (n = 9781) radiotherapy within one year after rectal cancer diagnosis were compared using a competing-risks analysis. Results: Rectal cancer patients with radiotherapy were at a significantly decreased risk of developing prostate cancer, with a hazard ratio (HR) of 0.41 (95% confidence interval = 0.20-0.83) after adjustment for age. Analysis of the risk estimated for various follow-up lengths suggested that a decreasing HR was seen through the period followed-up and that there was a trend of decreasing prostate cancer risk with time after radiotherapy. Conclusions: Radiotherapy was significantly associated with decreased risk of secondary prostate cancer among rectal cancer patients, by a magnitude of 59%.

Original languageEnglish
Article number104
JournalMedicina (Lithuania)
Volume55
Issue number4
DOIs
Publication statusPublished - 2019 Apr

Fingerprint

Rectal Neoplasms
Prostatic Neoplasms
Cohort Studies
Radiotherapy
Retrospective Studies
Population
Incidence
National Health Programs
Taiwan
Databases
Confidence Intervals
Survival
Research

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

@article{917e602e26a4472aa2be0f683d169548,
title = "A population-based study of secondary prostate cancer risk after radiotherapy in male patients with rectal cancer: A retrospective cohort study",
abstract = "Background and objective: Risk of secondary prostate cancer after radiation therapy among patients with rectal cancer remains undetermined. Given an increased incidence of rectal cancer in younger people and improved survival for rectal cancer patients who received radiation therapy, the potential risk of secondary prostate cancer needs to be further investigated. Materials and Methods: Male patients (n = 11,367) newly diagnosed rectal cancer and who underwent abdominoperineal resection (APR) or low anterior resection (LAR) from 1 January, 1998 to 31 December, 2010 were identified from Taiwan National Health Insurance Research Database. The incidence and relative risk of secondary prostate cancer in study patients with (n = 1586) and without (n = 9781) radiotherapy within one year after rectal cancer diagnosis were compared using a competing-risks analysis. Results: Rectal cancer patients with radiotherapy were at a significantly decreased risk of developing prostate cancer, with a hazard ratio (HR) of 0.41 (95{\%} confidence interval = 0.20-0.83) after adjustment for age. Analysis of the risk estimated for various follow-up lengths suggested that a decreasing HR was seen through the period followed-up and that there was a trend of decreasing prostate cancer risk with time after radiotherapy. Conclusions: Radiotherapy was significantly associated with decreased risk of secondary prostate cancer among rectal cancer patients, by a magnitude of 59{\%}.",
author = "Chuang, {Jen Pin} and Lee, {Yen Chien} and Lee, {Jenq Chang} and Lu, {Chin Li} and Li, {Chung Yi}",
year = "2019",
month = "4",
doi = "10.3390/medicina55040104",
language = "English",
volume = "55",
journal = "Medicina",
issn = "1010-660X",
publisher = "Kauno Medicinos Universitetas",
number = "4",

}

A population-based study of secondary prostate cancer risk after radiotherapy in male patients with rectal cancer : A retrospective cohort study. / Chuang, Jen Pin; Lee, Yen Chien; Lee, Jenq Chang; Lu, Chin Li; Li, Chung Yi.

In: Medicina (Lithuania), Vol. 55, No. 4, 104, 04.2019.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A population-based study of secondary prostate cancer risk after radiotherapy in male patients with rectal cancer

T2 - A retrospective cohort study

AU - Chuang, Jen Pin

AU - Lee, Yen Chien

AU - Lee, Jenq Chang

AU - Lu, Chin Li

AU - Li, Chung Yi

PY - 2019/4

Y1 - 2019/4

N2 - Background and objective: Risk of secondary prostate cancer after radiation therapy among patients with rectal cancer remains undetermined. Given an increased incidence of rectal cancer in younger people and improved survival for rectal cancer patients who received radiation therapy, the potential risk of secondary prostate cancer needs to be further investigated. Materials and Methods: Male patients (n = 11,367) newly diagnosed rectal cancer and who underwent abdominoperineal resection (APR) or low anterior resection (LAR) from 1 January, 1998 to 31 December, 2010 were identified from Taiwan National Health Insurance Research Database. The incidence and relative risk of secondary prostate cancer in study patients with (n = 1586) and without (n = 9781) radiotherapy within one year after rectal cancer diagnosis were compared using a competing-risks analysis. Results: Rectal cancer patients with radiotherapy were at a significantly decreased risk of developing prostate cancer, with a hazard ratio (HR) of 0.41 (95% confidence interval = 0.20-0.83) after adjustment for age. Analysis of the risk estimated for various follow-up lengths suggested that a decreasing HR was seen through the period followed-up and that there was a trend of decreasing prostate cancer risk with time after radiotherapy. Conclusions: Radiotherapy was significantly associated with decreased risk of secondary prostate cancer among rectal cancer patients, by a magnitude of 59%.

AB - Background and objective: Risk of secondary prostate cancer after radiation therapy among patients with rectal cancer remains undetermined. Given an increased incidence of rectal cancer in younger people and improved survival for rectal cancer patients who received radiation therapy, the potential risk of secondary prostate cancer needs to be further investigated. Materials and Methods: Male patients (n = 11,367) newly diagnosed rectal cancer and who underwent abdominoperineal resection (APR) or low anterior resection (LAR) from 1 January, 1998 to 31 December, 2010 were identified from Taiwan National Health Insurance Research Database. The incidence and relative risk of secondary prostate cancer in study patients with (n = 1586) and without (n = 9781) radiotherapy within one year after rectal cancer diagnosis were compared using a competing-risks analysis. Results: Rectal cancer patients with radiotherapy were at a significantly decreased risk of developing prostate cancer, with a hazard ratio (HR) of 0.41 (95% confidence interval = 0.20-0.83) after adjustment for age. Analysis of the risk estimated for various follow-up lengths suggested that a decreasing HR was seen through the period followed-up and that there was a trend of decreasing prostate cancer risk with time after radiotherapy. Conclusions: Radiotherapy was significantly associated with decreased risk of secondary prostate cancer among rectal cancer patients, by a magnitude of 59%.

UR - http://www.scopus.com/inward/record.url?scp=85065329977&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065329977&partnerID=8YFLogxK

U2 - 10.3390/medicina55040104

DO - 10.3390/medicina55040104

M3 - Article

C2 - 31013982

AN - SCOPUS:85065329977

VL - 55

JO - Medicina

JF - Medicina

SN - 1010-660X

IS - 4

M1 - 104

ER -